It continues with a global infrastructure of facilities strategically located around the world, linked to a robust, integrated IT network with superior reliability. MDS Pharma Services applies its advanced scientific and technological expertise throughout the drug discovery and development process – from lead optimization, pre-IND research, early clinical research (bioequivalence, phases I-IIa) and bioanalysis through to global clinical development (phases II-IV), central lab and centralized cardiac services.
It all comes together via an interconnected network of dedicated teams focused on managing your projects through the drug development continuum. More importantly, our capability and expertise to both customize and execute your research and development programs further accelerate your drug's development.
MDS Pharma Services has created a Drug Development Programs service that tailors our program management approach to meet the specific needs of each client, providing full program and scientific consulting, project management and program facilitation. Our Small Molecule Development Program is just one example of the versatility and scope available through Development and Regulatory Services.
From the start, MDS Pharma Services works with you as an integrated team. Our efforts are led by a senior level scientist/manager experienced in drug development who serves as the program leader. All aspects, including contracting, conduct and follow-up, are addressed through Development and Regulatory Services.
MDS in China
The MDS Beijing carries out the buiness mainly in the field of global clinical development (Phase â…¡-â…£).Six company-owned central lab facilities strategically located around the globe.Central lab in Beijing which had approved CAP (College of American Pathologists) in 2005.